InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

LeonaBio, Inc.

LONA Clue Score29
United States Fiscal year ends December CIK 0001620463 Results filed 14 Aug 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

35
Insider
Date
Role
Action
Shares
Price
Amount
Martin Javier San
4 Mar 2026
Chief Medical Officer
Sell
1,720
$5.37
$9.24K
Kevin Church
4 Mar 2026
Chief Scientific Officer
Sell
1,359
$5.37
$7.30K
Mark Worthington
4 Mar 2026
GENERAL COUNSEL and CCO
Sell
1,328
$5.37
$7.13K
Robert Renninger
4 Mar 2026
Chief Financial Officer
Sell
906
$5.37
$4.87K
Mark James Litton
4 Mar 2026
PRESIDENT and CEO
Sell
5,156
$5.37
$27.69K
Mark Worthington
2 Jan 2026
General Counsel and CCO
Sell
876
$6.88
$6.03K
Kevin Church
2 Jan 2026
Chief Scientific Officer
Sell
876
$6.88
$6.03K
Robert Renninger
2 Jan 2026
Chief Financial Officer
Sell
297
$6.88
$2.04K
Mark James Litton
2 Jan 2026
President and CEO
Sell
2,586
$6.88
$17.79K
Martin Javier San
2 Jan 2026
Chief Medical Officer
Sell
1,644
$6.88
$11.31K
Robert Renninger
1 Jul 2025
SVP, Finance and Accounting
Sell
2,897
$0.29
$850.27
Mark Worthington
1 Jul 2025
General Counsel and CCO
Sell
8,526
$0.29
$2.50K
Martin Javier San
1 Jul 2025
Chief Medical Officer
Sell
10,842
$0.29
$3.18K
Mark James Litton
1 Jul 2025
President and CEO
Sell
25,123
$0.29
$7.37K
Kevin Church
1 Jul 2025
Chief Scientific Officer
Sell
8,526
$0.29
$2.50K
Mark Worthington
2 Jan 2025
General Counsel and CCO
Sell
8,510
$0.56
$4.78K
Robert Renninger
2 Jan 2025
VP of Finance
Sell
2,881
$0.56
$1.62K
Kevin Church
2 Jan 2025
Chief Scientific Officer
Sell
8,510
$0.56
$4.78K
Mark James Litton
2 Jan 2025
President and CEO
Sell
25,107
$0.56
$14.11K
Martin Javier San
2 Jan 2025
Chief Medical Officer
Sell
10,826
$0.56
$6.08K
Mark James Litton
5 Sep 2024
President and CEO
Sell
5,032
$0.57
$2.85K
Mark Worthington
5 Sep 2024
General Counsel
Sell
2,525
$0.57
$1.43K
Kevin Church
5 Sep 2024
Chief Scientific Officer
Sell
2,525
$0.57
$1.43K
Rachel Lenington
5 Sep 2024
COO and CDO
Sell
2,525
$0.57
$1.43K
Andrew Gengos
5 Sep 2024
CFO and Chief Business Officer
Sell
1,272
$0.57
$719.95
Rachel Lenington
5 Jan 2024
Chief Operating Officer
Sell
2,412
$2.91
$7.02K
Mark Worthington
5 Jan 2024
General Counsel
Sell
2,412
$2.91
$7.02K
Mark James Litton
5 Jan 2024
Chief Executive Officer
Sell
4,820
$2.91
$14.03K
Kevin Church
5 Jan 2023
Chief Scientific Officer
Sell
2,412
$2.91
$7.02K
Andrew Gengos
5 Jan 2023
See Below
Sell
1,208
$2.91
$3.52K
Kevin Church
23 Jun 2022
Executive VP, Research
Sell
2,614
$2.69
$7.03K
Rachel Lenington
23 Jun 2022
Chief Operating Officer
Sell
4,193
$2.69
$11.28K
Mark James Litton
23 Jun 2022
Chief Executive Officer
Sell
7,960
$2.69
$21.41K
Glenna Mileson
23 Jun 2022
Chief Financial Officer
Sell
2,614
$2.69
$7.03K
Mark Worthington
23 Jun 2022
General Counsel
Sell
2,614
$2.69
$7.03K
Show all 81 transactions →

What was left out

Form 4 filings counted 177
Amendments (4/A) skipped 8
Filings about a different issuer 0
Unreadable filings 0
Joint filings 11
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 35
Transactions with no price 1
Shares from compensation/vesting 8,028,100
Sales filed before the plan box existed 5
History held since 22 Sep 2020